The company
Aclarion, Inc.
ACON · Nasdaq
ACON stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 30.6% below that average now. Diagnostics & Labs: 52% of its 44 stocks in an uptrend (+5 points in four weeks); Health Care: 28% (−9 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 52% +5 in 4 wk
- Insider buys, 12 months
- $353K
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 15 (+5)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Diagnostics & Labs: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Amanda M. WilliamsDirector | bought | 5,857at $2.73 | 17 Aug 2026filed 19 Aug 2026 |
| Gregory A. GouldCFO | bought | 10,000at $2.45 | 14 Aug 2026filed 18 Aug 2026 |
| Brent NessChief Executive Officer | bought | 5,234at $2.31 | 13 Aug 2026filed 17 Aug 2026 |
| David K. NealDirector | bought | 7,500at $2.40 | 13 Aug 2026filed 17 Aug 2026 |
| William WesemannDirector | bought | 2,150at $2.34 | 13 Aug 2026filed 17 Aug 2026 |
| Ryan BondDirector | bought | 21,122at $2.37 | 13 Aug 2026filed 17 Aug 2026 |
| Scott BreidbartDirector | bought | 5,664at $3.18 | 12 May 2026filed 12 May 2026 |
| Brent NessChief Executive Officer | bought | 6,289at $3.18 | 11 May 2026filed 11 May 2026 |
| David K. NealDirector | bought | 2,500at $3.10 | 11 May 2026filed 12 May 2026 |
| William WesemannDirector | bought | 1,562at $3.30 | 6 May 2026filed 8 May 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLCnew · filed 14 Aug 2026 | 19,480$56K | +19,480 |
| CAPTRUST FINANCIAL ADVISORSadded · filed 13 Aug 2026 | 17,059$49K | +2,500+17.2% |
| VANGUARD FIDUCIARY TRUST COnew · filed 13 Aug 2026 | 16,028$46K | +16,028 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLPnew · filed 14 Aug 2026 | 15,355$44K | +15,355 |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 12,128$35K | -19,087−61.1% |
| XTX Topco Ltdnew · filed 14 Aug 2026 | 11,038$32K | +11,038 |
| BANK OF MONTREALunchanged · filed 12 Aug 2026 | 10,000$29K | 00.0% |
| VANGUARD CAPITAL MANAGEMENT LLCunchanged · filed 13 Aug 2026 | 6,782$20K | 00.0% |
| OSAIC HOLDINGS, INC.reduced · filed 14 Aug 2026 | 5,000$14K | -29,945−85.7% |
| UBS Group AGreduced · filed 13 Aug 2026 | 1,968$5,668 | -7,679−79.6% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.